trial · primary record
ALV-100
Overweight , Obesity
| Phase | Phase 2 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 220 |
| Primary completion | 2027-08-24 |
| Primary endpoint | Dose response of ALV-100 as assessed by maintenance of weight loss |
| Registry ID | NCT07837973 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-28T02:32:43.440Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT07837973
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.